1
Reed Steven G: Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production. Corixa, November 5, 1997: EP0804581-A1 (15 worldwide citation)

Compounds and methods for stimulating and enhancing immune responses and for evaluating patient immune responses are disclosed. Disclosed compounds include polypeptides that contain at least a biologically active portion of a Leshmania braziliensis homolog of the eukaryotic initiation factor 4A, or ...


2
Reed Steven G, Carter Darrick: Vaccine composition containing synthetic adjuvant. Infectious Disease Research Institute, Reed Steven G, Carter Darrick, HERMANNS Karl R, December 18, 2008: WO/2008/153541 (15 worldwide citation)

Compositions and methods, including vaccines and pharmaceutical compositions for inducing or enhancing an immune response are disclosed based on the discovery of useful immunological adjuvant properties in a synthetic, glucopyranosyl lipid adjuvant (GLA) that is provided in substantially homogeneous ...


3
Reed Steven G, Carter Darrick: Vaccine composition containing synthetic adjuvant. Infectious Disease Research Institute, Reed Steven G, Carter Darrick, Hermanns Karl R, November 26, 2009: WO/2009/143457 (14 worldwide citation)

Compositions and methods, including vaccines and pharmaceutical compositions for inducing or enhancing an immune response are disclosed based on the discovery of useful immunological adjuvant properties in a synthetic, glucopyranosyl lipid adjuvant (GLA) that is provided in substantially homogeneous ...


4
REED STEVEN G: Synthetic glucopyranosyl lipid adjuvants. INFECTIOUS DISEASE RESEARCH INSTITUTE, Hundley Jeffrey E, December 9, 2010: WO/2010/141861 (13 worldwide citation)

Compounds, particularly, glucopyranosyl lipid adjuvant (GLA) compounds, having the following structure (I) are provided:(I) or a pharmaceutically acceptable salt thereof, wherein L1, L2, L3, L4, L5, L6, L7, L8, L9, L10, Y1,Y2, Y3, Y4, R1, R2, R3, R4, R5, R6, are as defined herein. Pharmaceutical com ...


5
Frudakis Tony N, Smith John M, Reed Steven G: Corixa Corporation, sMAKI David J, July 17, 1997: WO/1997/025426 (9 worldwide citation)

Compositions and methods for the detection and therapy of breast cancer are disclosed. The compounds provided include nucleotide sequences that are preferentially expressed in breast tumor tissue, as well as polypeptides encoded by such nucleotide sequences. Vaccines and pharmaceutical compositions ...


6
Matsumura Akihiko, Reed Steven G: Iontophoretic device and method for administering immune response-enhancing agents and compositions. Transcutaneous Technologies, Matsumura Akihiko, Reed Steven G, ABRAMONTE Frank, May 26, 2006: WO/2006/055729 (8 worldwide citation)

An iontophoresis device and method delivers an immune response-enhancing agent, or composition thereof via iontophoresis. The device may include an active electrode assembly having a drug solution holding portion, comprising an immune response-enhancing agent, or composition thereof; and a non-activ ...


7
Reed Steven G, Lodes Michael J, Houghton Raymond, Sleath Paul R: Compounds and methods for the diagnosis and treatment of babesia microti infection. Corixa, April 8, 1998: EP0834567-A2 (6 worldwide citation)

Compounds and methods for the diagnosis and treatment of B. microti infection are disclosed. The compounds provided include polypeptides that contain at least one antigenic portion of a B. microti antigen and DNA sequences encoding such polypeptides. Antigenic epitopes of such antigens are also prov ...


8
Reed Steven G, Carter Darrick: Vaccine composition containing synthetic adjuvant. Infectious Disease Res Inst, June 17, 2009: EP2068918-A1 (5 worldwide citation)

Compositions and methods, including vaccines and pharmaceutical compositions for inducing or enhancing an immune response are disclosed based on the discovery of useful immunological adjuvant properties in a synthetic, glucopyranosyl lipid adjuvant (GLA) that is provided in substantially homogeneous ...


9
Reed Steven G: Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof. Infectious Disease Research Institute, Reed Steven G, CHRISTIANSEN William T, October 16, 2008: WO/2008/124647 (5 worldwide citation)

The present invention relates to compositions and fusion proteins containing at least two Mycobacterium sp. antigens, and polynucleotides encoding such compositions and fusion proteins. The invention also relates to methods for their use in the treatment, prevention and/or diagnosis of tuberculosis ...


10
Reed Steven G: Compounds and methods for diagnosis of leishmaniasis. Corixa, February 13, 2002: EP1179733-A1 (4 worldwide citation)

Compounds and methods are provided for diagnosing Leishmania infection. Disclosed compounds include polypeptides that contain at least an epitope of the Leishmania chagasi acidic ribosomal antigen LcP0, or a variant thereof. Such compounds are useful in a variety of immunoassays for detecting Leishm ...